Rosette Lidereau

26.9k total citations · 2 hit papers
263 papers, 16.1k citations indexed

About

Rosette Lidereau is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Rosette Lidereau has authored 263 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Molecular Biology, 108 papers in Oncology and 80 papers in Genetics. Recurrent topics in Rosette Lidereau's work include Cancer-related Molecular Pathways (47 papers), Cancer Genomics and Diagnostics (41 papers) and Genetic factors in colorectal cancer (29 papers). Rosette Lidereau is often cited by papers focused on Cancer-related Molecular Pathways (47 papers), Cancer Genomics and Diagnostics (41 papers) and Genetic factors in colorectal cancer (29 papers). Rosette Lidereau collaborates with scholars based in France, United States and Italy. Rosette Lidereau's co-authors include Ivan Bièche, Robert Callahan, Michel Vidaud, Sengül Tozlu, Sophie Vacher, Keltouma Driouch, Charles Theillet, Igor Girault, M.H. Champème and Martine Olivi and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Rosette Lidereau

259 papers receiving 15.7k citations

Hit Papers

Validation and Clinical Utility of a 70-Gene Prognostic S... 2006 2026 2012 2019 2006 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
    2006 842 citations Rosette Lidereau et al. profile →
  2. Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
    2007 726 citations Rosette Lidereau et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosette Lidereau France 70 9.5k 6.3k 5.0k 3.3k 2.0k 263 16.1k
Åke Borg Sweden 75 10.3k 1.1× 6.9k 1.1× 6.8k 1.4× 5.1k 1.6× 2.1k 1.1× 275 18.7k
Suzanne A.W. Fuqua United States 69 9.3k 1.0× 6.4k 1.0× 4.0k 0.8× 6.6k 2.0× 1.3k 0.6× 203 16.6k
Robert L. Sutherland Australia 78 10.4k 1.1× 7.8k 1.2× 3.8k 0.8× 5.0k 1.5× 1.2k 0.6× 236 19.2k
Ivan Bièche France 76 11.1k 1.2× 5.9k 0.9× 5.7k 1.1× 2.7k 0.8× 1.7k 0.8× 497 20.2k
Shirley Zhu United States 34 8.3k 0.9× 7.2k 1.1× 7.0k 1.4× 1.9k 0.6× 2.0k 1.0× 52 17.1k
Celina G. Kleer United States 65 9.2k 1.0× 7.9k 1.3× 5.8k 1.2× 1.3k 0.4× 2.0k 1.0× 174 17.2k
Varda Rotter Israel 77 11.9k 1.3× 10.2k 1.6× 4.1k 0.8× 1.8k 0.5× 1.1k 0.5× 270 18.4k
Elizabeth A. Musgrove Australia 60 7.4k 0.8× 6.6k 1.1× 3.2k 0.6× 3.0k 0.9× 1.3k 0.6× 144 13.6k
Jennifer A. Pietenpol United States 61 12.1k 1.3× 11.7k 1.9× 5.5k 1.1× 1.7k 0.5× 1.3k 0.7× 145 20.2k
Stephanie Geisler Norway 21 7.5k 0.8× 7.4k 1.2× 7.2k 1.4× 2.5k 0.7× 1.7k 0.9× 36 14.5k

Countries citing papers authored by Rosette Lidereau

Since Specialization
Citations

This map shows the geographic impact of Rosette Lidereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosette Lidereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosette Lidereau more than expected).

Fields of papers citing papers by Rosette Lidereau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosette Lidereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosette Lidereau. The network helps show where Rosette Lidereau may publish in the future.

Co-authorship network of co-authors of Rosette Lidereau

This figure shows the co-authorship network connecting the top 25 collaborators of Rosette Lidereau. A scholar is included among the top collaborators of Rosette Lidereau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosette Lidereau. Rosette Lidereau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petitalot, Ambre, Elodie Dardillac, Eric Jacquet, et al.. (2018). Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk. Molecular Cancer Research. 17(1). 54–69. 19 indexed citations
2.
Meseure, Didier, Sophie Vacher, Kinan Drak Alsibai, et al.. (2016). Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value. Molecular Cancer Research. 14(7). 623–633. 82 indexed citations
3.
Hassanein, Mohamed, Laëtitia Huiart, Violaine Bourdon, et al.. (2013). Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67. Pathobiology. 80(5). 219–227. 10 indexed citations
4.
Čížková, Magdalena, A. Susini, Sophie Vacher, et al.. (2012). PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups. Breast Cancer Research. 14(1). R28–R28. 143 indexed citations
5.
Bennetau, Bernard, Rosette Lidereau, Laurent Thomas, et al.. (2010). A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients. Biomedical Microdevices. 13(1). 1–9. 10 indexed citations
6.
Dutertre, Martin, Magali Lacroix‐Triki, Keltouma Driouch, et al.. (2010). Exon-Based Clustering of Murine Breast Tumor Transcriptomes Reveals Alternative Exons Whose Expression Is Associated with Metastasis. Cancer Research. 70(3). 896–905. 53 indexed citations
7.
Dutertre, Martin, Lise Gratadou, Étienne Dardenne, et al.. (2010). Estrogen Regulation and Physiopathologic Significance of Alternative Promoters in Breast Cancer. Cancer Research. 70(9). 3760–3770. 65 indexed citations
8.
Coulet, Florence, Étienne Rouleau, Cédrick Lefol, et al.. (2010). A One-Step Prescreening for Point Mutations and Large Rearrangement in BRCA1 and BRCA2 Genes Using Quantitative Polymerase Chain Reaction and High-Resolution Melting Curve Analysis. Genetic Testing and Molecular Biomarkers. 14(5). 677–690. 16 indexed citations
9.
Shehata, Mona, Ivan Bièche, Rose Boutros, et al.. (2008). Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52. Clinical Cancer Research. 14(16). 5050–5060. 52 indexed citations
10.
Jackson, Amanda, Akeila Bellahcène, Nadia Rucci, et al.. (2008). A Six-Gene Signature Predicting Breast Cancer Lung Metastasis. Cancer Research. 68(15). 6092–6099. 121 indexed citations
11.
Cohen, Pascale A., Ivan Bièche, Julie A. Vendrell, et al.. (2008). mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels. European Journal of Cancer Supplements. 6(9). 83–83. 1 indexed citations
12.
Buijs, Jeroen T., Nico V. Henriquez, Petra G.M. van Overveld, et al.. (2007). Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer. Cancer Research. 67(18). 8742–8751. 157 indexed citations
13.
Bièche, Ivan, Carine Chavey, Catherine Andrieu, et al.. (2007). CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocrine Related Cancer. 14(4). 1039–1052. 145 indexed citations
14.
Amsellem‐Ouazana, Delphine, Ivan Bièche, Vincent Molinié, et al.. (2006). Is Quantitative Real-Time RT-PCR an Adjunct to Immunohistochemistry for the Evaluation of ErbB2 Status in Transitional Carcinoma of the Bladder?. European Urology. 49(6). 1035–1043. 5 indexed citations
15.
Bossard, Céline, et al.. (2006). Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma.. PubMed. 25(6C). 4679–83. 21 indexed citations
16.
Bièche, Ivan, Florence Lerebours, Sengül Tozlu, et al.. (2004). Molecular Profiling of Inflammatory Breast Cancer. Clinical Cancer Research. 10(20). 6789–6795. 188 indexed citations
17.
Bièche, Ivan, Béatrice Parfait, Catherine Noguès, et al.. (2001). The CGA gene as new predictor of the response to endocrine therapy in ERα-positive postmenopausal breast cancer patients. Oncogene. 20(47). 6955–6959. 17 indexed citations
18.
Bièche, Ivan, Béatrice Parfait, Martine Olivi, et al.. (2001). Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.. PubMed. 61(4). 1652–8. 115 indexed citations
19.
Bièche, Ivan, Peter Onody, Ingrid Laurendeau, et al.. (1999). Real-Time Reverse Transcription-PCR Assay for Future Management of ERBB2-based Clinical Applications. Clinical Chemistry. 45(8). 1148–1156. 219 indexed citations
20.
Bièche, Ivan & Rosette Lidereau. (1997). Génétique somatique du cancer du sein. Bulletin du Cancer. 84(1). 83–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Åke Borg Breakdown of academic impact, for papers by Suzanne A.W. Fuqua Breakdown of academic impact, for papers by Robert L. Sutherland Breakdown of academic impact, for papers by Ivan Bièche Breakdown of academic impact, for papers by Shirley Zhu Breakdown of academic impact, for papers by Celina G. Kleer Breakdown of academic impact, for papers by Varda Rotter Breakdown of academic impact, for papers by Elizabeth A. Musgrove Breakdown of academic impact, for papers by Jennifer A. Pietenpol Breakdown of academic impact, for papers by Stephanie Geisler
Rankless by CCL
2026